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Abstract
Background: To produce statements based on the available evidence and an expert consensus (as members of
the Lung Ultrasound Working Group of the Italian Society of Analgesia, Anesthesia, Resuscitation, and Intensive
Care, SIAARTI) on the use of lung ultrasound for the management of patients with COVID-19 admitted to the
intensive care unit.
Methods: A modified Delphi method was applied by a panel of anesthesiologists and intensive care physicians
expert in the use of lung ultrasound in COVID-19 intensive critically ill patients to reach a consensus on ten clinical
questions concerning the role of lung ultrasound in the following: COVID-19 diagnosis and monitoring (with and
without invasive mechanical ventilation), positive end expiratory pressure titration, the use of prone position, the
early diagnosis of pneumothorax- or ventilator-associated pneumonia, the process of weaning from invasive
mechanical ventilation, and the need for radiologic chest imaging.
Results: A total of 20 statements were produced by the panel. Agreement was reached on 18 out of 20 statements
(scoring 7–9; “appropriate”) in the first round of voting, while 2 statements required a second round for agreement
to be reached. At the end of the two Delphi rounds, the median score for the 20 statements was 8.5 [IQR 8.9], and
the agreement percentage was 100%.
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Conclusion: The Lung Ultrasound Working Group of the Italian Society of Analgesia, Anesthesia, Resuscitation, and
Intensive Care produced 20 consensus statements on the use of lung ultrasound in COVID-19 patients admitted to
the ICU. This expert consensus strongly suggests integrating lung ultrasound findings in the clinical management of
critically ill COVID-19 patients.
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Introduction
The use of lung ultrasound (LUS) in the intensive care set-
ting has increased during the coronavirus disease 2019
(COVID-19) pandemic. It is being employed as a diagnos-
tic and monitoring tool in patients with COVID-19-
related pneumonia—a condition which in some cases
evolves into acute respiratory distress syndrome (ARDS)
[1]. Lung ultrasound presents many advantages over other
imaging techniques: it is readily available at the bedside,
thus avoiding the need to transport patients to the radi-
ology department, and it is radiation-free and highly re-
peatable, making it suitable for lung monitoring purposes
[2]. Lung damage in COVID-19 pneumonia is mainly lo-
calized to the peripheral regions of the lungs, thus easily
accessible to ultrasound [3]. The sensitivity and negative
predictive value of LUS for COVID-19 pneumonia are
both higher compared with those for chest X-ray [4].
Moreover, many studies show a close correlation between
LUS and computed tomography (CT) scan findings [5].
Given the prolonged need for mechanical ventilation in
COVID-19 and long intensive care unit (ICU) stay, re-
peated lung assessments are usually required. CT remains
the reference imaging technique for lung assessment, but
it is unsuitable as a monitoring tool due to its use of ioniz-
ing radiation. It also necessitates patient contact with
healthcare providers outside the ICU, increasing the op-
portunity for this highly infectious disease to spread. The
quantitative evaluation of lung disease by means of the
LUS score provides a reliable method for assessing lung
aeration in both ARDS and COVID-19, and may further
help in monitoring lung recovery and in the daily
optimization of ventilation strategies (i.e., positive end-
expiration pressure [PEEP] titration, and the use of prone
positioning) [6]. Finally, LUS permits the early bedside de-
tection of complications, such as pneumothorax [7] and
ventilator-associated pneumonia [8]. As a consequence,
LUS has earned a leading position in the management of
COVID-19 patients, being a reliable, time-sparing, and
easy-to-learn alternative to traditional imaging techniques
[9, 10]. However, the recent literature is mainly focused
on its applications within the Emergency Department
[11]. Although Canadian Internal Medicine Ultrasound
(CIMUS) experts recently established their recommenda-
tions for medical inpatients with COVID-19 [12], consen-
sus guidelines dedicated to COVID-19 ICU patients and
officially acknowledged by a national intensive care
scientific society are lacking. To fill this gap, we aimed to
produce an expert consensus on the bedside use of LUS
in critically ill COVID-19 patients by a national panel of
anesthesiology and intensive care physicians.
Methods
Consensus process design
This project was conducted according to a modified Del-
phi method to reach consensus on key aspects of the use
of LUS in critically ill patients with COVID-19. Discus-
sions were based on the available scientific evidence as
well as the panel of experts’ own clinical experience. The
experts were selected by the project coordinators (LV
and FM) based not only on their clinical and scientific
interest in the topic [13] but also the opinion of intensi-
vists who are not experts in LUS but who understand
the context of critically ill COVID patients, and the po-
tential role of lung ultrasound was invited. After an ini-
tial (online) kick-off meeting between the coordinators,
the panelists, the methodologists (AC and DP), and the
evidence review team (MI and DO), the project coordi-
nators proposed a list of the most relevant clinical ques-
tions to the whole panel, which was then asked to
submit a blind boolean vote (“agree/disagree on the rele-
vance”) as well as comments and proposals for their
modification. In response, the coordinators made the ap-
propriate changes to the clinical questions, which were
finally approved by the whole panel through a second
round of voting. The coordinators then assigned the
work on each clinical question to a designated group of
experts, each of which was led by a designated group
head (PP, PN, EB, TB, and SM). The list of clinical ques-
tions and the final consensus-based statements is shown
in Table 1.
Systematic review of available evidence
A systematic review of MEDLINE, PubMed, EMBASE,
and pre-print depositories (medRxiv and bioRxiv) was
performed by the evidence review team with the added
input of AC. The full search strategy can be found in
Additional file 1. Inclusion and exclusion criteria and
the PRISMA flow diagram (Fig. S1) of the inclusion/ex-
clusion process can be found in Additional file 2 with
the results of the first round of voting (Fig. S2). The full
output of the search and the selection of potentially rele-
vant articles (selected by MI and DO, according to the
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Table 1 List of clinical questions and final consensus-based statements
10-clinical questions 20-consensus-based statements
A) Does LUS have a role to play in the diagnosis of COVID-19? Statement 1: LUS should be integrated in the clinical workup to diagnose
COVID-19 pneumonia.
Statement 2: In patients with high clinical suspicion of COVID-19 and LUS
findings compatible with ultrasonographic interstitial pneumonia, a nega-
tive nasal/oropharyngeal RT-PCR should not be used alone to exclude
COVID-19.
Statement 3: LUS should not be used alone to rule out SARS-CoV-2 pneu-
monia in suspected COVID-19.
B) Can LUS help in the early assessment of COVID-19 severity in the
Emergency Department and/or at ICU admission?
Statement 4: Sonographic multifocal and bilateral pleural and lung
abnormalities, a high overall LUS score, and/or a high score in the gravity
dependent areas can be used for the early assessment of COVID-19 sever-
ity in the Emergency Department and at ICU admission since all correlate
with worsening patient outcomes – intended as the need for ICU admis-
sion, NIV, intubation, and a higher mortality rate.
C) Can LUS be used as a lung monitoring tool in COVID-19 patients
undergoing non-invasive respiratory support (HFNC, CPAP, or NIV)?
Statement 5: In COVID-19 patients undergoing non-invasive respiratory
support (HFNC, CPAP or NIV), LUS integrated with clinical and physio-
logical parameters may contribute to predict non-invasive respiratory sup-
port outcome and early detect complications.
D) Can LUS be used as a lung monitoring tool in COVID-19 patients
undergoing invasive mechanical ventilation?
Statement 6: LUS should be integrated into the multimodal assessment
of disease progression and the response to treatments in mechanically
ventilated COVID-19 patients.
Statement 7: LUS should be integrated into the clinical decision-making
process and monitoring of procedures, such as fibrobronchoscopy, in
mechanically ventilated COVID-19 patients.
Statement 8: LUS should be integrated into the clinical decision-making
process and monitoring of treatments, such as antibiotics, in mechanically
ventilated COVID-19 patients.
Statement 9: LUS should be integrated into the clinical decision-making
process and monitoring of fluid removal in mechanically ventilated
COVID-19 patients.
E) Can LUS guide the titration of positive end expiratory pressure in
severe COVID-19 patients receiving invasive mechanical ventilation?
Statement 10: LUS should be considered as an additional tool for PEEP
titration in COVID-19.
F) Can LUS guide the use of prone positioning in patients with severe
COVID-19?
Statement 11: LUS should be integrated into the assessment of patients
considered potential responders to prone positioning, according to the
focal and non-focal pattern of lung aeration loss.
Statement 12: LUS can be used to monitor variations in lung aeration
during prone positioning.
G) Can LUS help early diagnosis of pneumothorax in severe COVID-19
patients undergoing invasive mechanical ventilation?
Statement 13: LUS should be used in COVID-19 patients, in line with its
clinical appropriateness as ascertained by studies in non-COVID-19
patients.
H) Can LUS help the early diagnosis of ventilator-associated pneumonia
in severe COVID-19 patients undergoing invasive mechanical ventilation?
Statement 14: LUS should be used in COVID-19 patients, in line with its
clinical appropriateness as ascertained by studies in non-COVID-19
patients.
I) Can LUS help the process of weaning severe COVID-19 patients from
invasive mechanical ventilation?
Statement 15: We are unable to create any statement on the use of LUS
in the assessment of patient readiness to sustain a spontaneous breathing
trial (SBT). No study has evaluated the potential of LUS for this purpose in
COVID-19 patients, and data in non-COVID-19 patients are conflicting.
Statement 16: In association with standard clinical and physiological
indexes, LUS can improve the prediction of SBT outcome in COVID-19
patients.
Statement 17: In association with standard clinical and physiological
indexes, LUS can improve the prediction of extubation failure in COVID-19
patients.
L) Can LUS decrease the need for radiologic chest imaging in severe
COVID-19 patients?
Statement 18: In patients with known COVID-19 and severe symptoms,
LUS should be performed instead of radiologic chest imaging as the first-
line imaging test to monitor disease progression.
Statement 19: LUS findings suggestive of pneumonia can render
additional imaging techniques unnecessary, especially when the likelihood
of an alternative diagnosis is low.
Statement 20: In COVID-19 patients with severe symptoms, a negative
LUS exam should prompt an additional radiologic chest imaging work-up.
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PICO questions and criteria described in Table S1, Add-
itional file 2) can be found in Additional file 3. The last
literature search was completed on 16 January 2021.
Other sources (i.e., reference lists from relevant articles
[i.e., the snowballing method] and online journal issues)
were surveyed after the last literature search and up until
the end of the first round of voting so that any further
relevant articles could be identified and included. The
output of the search together with the full texts of all
relevant articles was then sent to all panelists. Following
the evaluation of the evidence, each panelist produced
their statement and rationale in response to each of the
given questions.
The Delphi rounds, consensus meeting
Two rounds of voting were held between March and
June 2021. The respondents were blinded to each other’s
responses. In the first round, expert panelists responded
to the online questionnaire and were offered the possi-
bility of adding their opinions using an open text box.
The research assistance team (CC, see the “Acknowl-
edgements” section), with the input of the methodologist
(AC), assessed and presented the results from round 1 in
the form of bar graphs to facilitate the comments and
clarifications offered by each participant during an on-
line meeting. During this meeting, the panel openly dis-
cussed the statements/rationales on which agreement
had not been reached. In some circumstances the dis-
cussion led the panelists to reconsider their initial opin-
ions, whereas in others it resulted in the working group
modifying the statements. A second round of blind on-
line voting was then held. The results of the consensus
process were tabulated and presented both descriptively
and graphically. The process was closed on 16 June
2021.
Questionnaire and consensus criteria
The group’s opinion on each statement and rationale
was studied in terms of the score and the level of con-
sensus reached by the panelists. The same criteria were
applied to each of the statements and rationales. Opin-
ions were expressed using a unique nine-point ordinal
Likert-type scale, according to the model developed by
UCLA-RAND Corporation (minimum score, 1 = full dis-
agreement; maximum score, 9 = full agreement) [13].
This scale was split into three sections, indicating the
level of agreement/disagreement: a score of 1–3 impli-
cated rejection or disagreement (“not appropriate”); 4–6
implicated (“uncertainty”); and 7–9 implicated agree-
ment/support (“appropriate”). Consensus was reached
when (i) 75% or more of the respondents, i.e., at least 14
out of 18 experts (excluding the methodologists and the
evidence review team), assigned a score within the 3-
point ranges 1–3 or 7–9, which rejected or accepted the
statements/rationales, respectively; and (ii) the median
score also lay within these ranges [14]. The type of con-
sensus achieved was determined by the median score:
“agreement” was defined for a median score ≥ 7, and
“disagreement” for a median score ≤ 3. A median score
within the 4–6 range meant that most of the group had
scored the items as “uncertain.”
Results
The panel was composed of a total of 18 experts, 4
methodologists, and 2 senior heads. The panel produced
a total of 20 statements. The criteria for a consensus of
agreement (i.e., a score in the range 7–9 provided by
75% or more of respondents, and a median score value
also within this range) were met for 18 out of 20 state-
ments in the first round of voting. Consensus was not
achieved in relation to statements no. 5 and no. 17 (see
Fig. S2, Additional file 2). After the second round of vot-
ing, consensus of agreement was achieved on all state-
ments. The median score (plus interquartile range) and
agreement percentage for all the statements contained in
the final consensus report are shown in Fig. 1.
Clinical questions and consensus-based statements
A) Does LUS have a role to play in the diagnosis of
COVID-19?
Statement 1: LUS should be integrated in the clinical
workup to diagnose COVID-19 pneumonia.
Statement 2: In patients with high clinical suspicion of
COVID-19 and LUS findings compatible with ultra-
sonographic interstitial pneumonia, a negative nasal/
oropharyngeal RT-PCR should not be used alone to ex-
clude COVID-19.
Statement 3: LUS should not be used alone to rule in
and rule out SARS-CoV-2 pneumonia in suspected
COVID-19.
Lung ultrasound has been shown to improve the diag-
nostic accuracy in patients who present with acute re-
spiratory symptoms [15]. The reliance on the clinical
presentation of patients is a highly ineffective approach
for COVID-19 case identification. The sensitivity of
using crackles on auscultation for the detection of par-
enchymal involvement in COVID-19 patients was just
8% when compared to CT as reference [11]. On the con-
trary, LUS performs better than standard tests for dys-
pnea in the Emergency Department [16, 17], permitting
COVID-19 pneumonia to be diagnosed in patients with
normal vital signs [11], and distinguishing between viral
and bacterial pneumonias [17]. LUS is more accurate
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Fig. 1 The median score (plus interquartile range) and agreement percentage for all the statements contained in the final consensus report
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than chest X-ray in diagnosing respiratory conditions
[18, 19], including interstitial diseases [20], pneumonia
[21], and COVID-19 pneumonia [22]. If the pre-test
probability of COVID-19 is low [23], a LUS bilateral A-
pattern with sliding makes COVID-19 pneumonia un-
likely owing to its high negative predictive value for
pneumonia [24, 25]. The strong correlation between CT
and LUS scans in COVID-19 patients supports the pref-
erential use of LUS over CT in scenarios where CT is in-
appropriate (e.g., pregnancy) or difficult to obtain [26].
Real-time polymerase chain reaction (RT-PCR) testing is
currently the standard diagnostic test for SARS-CoV-2
infection, and it is reported to have high specificity but
only moderate sensitivity for diagnosing COVID-19 [27,
28]. Coupled with pre-test probability, bilateral B-lines,
an irregular pleural line, and sub-pleural consolidations
increase the likelihood of COVID-19 diagnosis [29, 30].
A recent meta-analysis of six observational studies and a
case series describing a total of 122 symptomatic pa-
tients highlights the role of LUS in the diagnosis of
COVID-19 [31]. Interstitial lung involvement, as
depicted by the B-pattern, was the most common and
consistent finding by LUS, and the presence of this find-
ing in addition to other characteristic symptoms will in-
crease the likelihood of diagnosis. The “light beam”
artifact is a LUS sign that corresponds to the early ap-
pearance of “ground-glass” opacity on a CT scan, and it
has been observed in most patients with COVID-19
pneumonia [32, 33]. Some authors have suggested the
“light beam” sign to be specific to COVID-19 pneumo-
nia, and its presence may increase the diagnostic likeli-
hood in patients suspected of having COVID-19 [1].
However, LUS should always be integrated into a more
comprehensive clinical evaluation, and LUS findings
should be interpreted in light of the pre-test probability
of COVID-19 pneumonia.
B) Can LUS help in the early assessment of COVID-19
severity in the Emergency Department and/or at
ICU admission?
Statement 4: Sonographic multifocal and bilateral
pleural and lung abnormalities, a high overall LUS
score, and/or a high score in the gravity dependent
areas can be used for the early assessment of
COVID-19 severity in the Emergency Department
and at ICU admission since all correlate with wors-
ening patient outcomes—intended as the need for
ICU admission, non-invasive ventilation (NIV), in-
tubation, and a higher mortality rate—although ICU
admission still remains a clinical decision based on
clinical assessment and some related exams.
Several observational prospective cohort studies of
COVID-19 patients have found a significant correlation
between LUS findings and poor outcome, defined as
ICU admission, increased likelihood of acute respiratory
failure, the need for non-invasive or invasive mechanical
ventilation, and a higher hospital mortality rate [34, 35].
In all these studies, LUS scores were based on a 4-level
scoring system ranging from 0 to 3, but they differed in
the number of areas scanned, which ranged from 6 to 14
lung regions [34–55]. Two groups of researchers ana-
lyzed the agreement between the different LUS score
protocols and patient outcome in COVID-19 patients
and concluded that, independently of the number of
areas scanned, the accuracy in outcome prediction was
higher when the protocol adopted included the evalu-
ation of the gravity dependent areas [44, 45]. One case
series and sixteen observational prospective cohort stud-
ies have provided consistent results suggesting that, in-
dependently of the protocol adopted, a moderate loss of
aeration as assessed by LUS is associated with a higher
need for NIV, whereas a severe loss of lung aeration is
associated with an increased likelihood of ICU admission
and mortality [34–41, 43–49, 51, 54]. In five observa-
tional prospective studies [40–42, 54, 55], an increased
likelihood of NIV failure was associated with a severe
loss of lung aeration as assessed by the LUS score, inde-
pendently of the protocol adopted. In the light of this
evidence, and independently of the number of areas
scanned and the LUS score protocol adopted, the pres-
ence of sonographic multifocal and bilateral pleural and
lung abnormalities together with a high overall LUS
score and/or high scores in the gravity dependent areas
may help in predicting NIV failure, the need for ICU ad-
mission, and hospital mortality in the emergency room.
The 12-lung-region scoring system usually adopted in
critically ill patients is described in Fig. 2.
C) Can LUS be used as a lung monitoring tool in
COVID-19 patients undergoing non-invasive re-
spiratory support (HFNC, CPAP, or NIV)?
Statement 5: In COVID-19 patients undergoing non-
invasive respiratory support (HFNC, CPAP, or NIV),
LUS integrated with clinical and physiological parame-
ters may contribute to predict non-invasive respiratory
support outcome and early detect complications.
Although robust evidence in COVID-19 patients has
yet to be gathered, apart from some interesting case
series [56, 57] and a few observational cohort studies in-
volving small sample sizes [58, 59], the role of LUS as a
monitoring tool in the field of interstitial lung diseases
has already been confirmed since the LUS score is
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known to correlate with lung aeration [60]. Based on all
the evidence available in this setting [37, 39–41, 43, 49,
54, 56, 58], the daily assessment of the LUS score in
COVID-19 patients undergoing non-invasive respiratory
support can be considered an appropriate approach. A
worsening overall LUS score, with or without a high
LUS score in the gravity dependent areas, may be pre-
dictive of a worsening patient outcome and the failure of
a 24-h non-invasive respiratory support trial [40–42, 54,
56]. On the other hand, a stable or decreasing overall
LUS score after a 24-h non-invasive respiratory support
trial, together with an improvement in the LUS score in
the gravity dependent areas, may be associated with
non-invasive respiratory support success. Furthermore,
pneumothorax (PNX) and pneumomediastinum are
common complications in severe COVID-19 respiratory
failure [61, 62], even in patients undergoing non-invasive
ventilation, especially if associated with exacerbating in-
spiratory efforts and high pleural pressure swings. The
role of LUS in the early detection and monitoring of
PNX is well-known. In fact, the sensitivity and specificity
of LUS for the detection of even small occult PNX have
been demonstrated to be high [63, 64]. In patients with-
out subcutaneous emphysema, pneumomediastinum
may be suspected once PNX has been ruled out in the
presence of specific ultrasound findings in the subxi-
phoid view and/or in the anterolateral cervical region
[65, 66].
D) Can LUS be used as a lung monitoring tool in
COVID-19 patients undergoing invasive mechanical
ventilation?
Statement 6: LUS should be integrated into the
multimodal assessment of disease progression and the
response to treatments in mechanically ventilated
COVID-19 patients.
Statement 7: LUS should be integrated into the clinical
decision-making process and monitoring of procedures,
such as fibrobronchoscopy, in mechanically ventilated
COVID-19 patients.
Statement 8: LUS should be integrated into the clinical
decision-making process and monitoring of treatments,
such as antibiotics, in mechanically ventilated COVID-
19 patients.
Statement 9: LUS should be integrated into the clinical
decision-making process and monitoring of fluid re-
moval in mechanically ventilated COVID-19 patients.
Specific ultrasound findings provide useful information
for the monitoring of mechanically ventilated patients
[60, 67]. A complete examination requires only a few
minutes and shows high inter-observer agreement even
with ultra-portable devices [8–68]. Changes in the LUS
score over time may help the assessment of disease pro-
gression and of the response to treatments in ARDS pa-
tients [69–72]. Monitoring the lung with LUS may
improve the management of fluid balance in acute re-
spiratory failure patients [73, 74]. The visualization of a
newly appeared tissue-like pattern could point toward/
be suggestive of reabsorption atelectasis (if a static or ab-
sent air-bronchogram is visualized) [75], ventilator-
associated pneumonia (dynamic linear/arborescent air-
bronchogram), or lung collapse with patent airways (dy-
namic punctiform air-bronchogram), thus indicating the
need for dis-obstructive fibro-bronchoscopy, distal
micro-biological sampling, or titration of positive pres-
sure mechanical ventilation [76]. Pleural line assessment
is also of interest in COVID-19 patients. The results of
an in vitro study suggest that the persistence of sub-
pleural consolidations and pleural irregularities may be a
marker of fibro-proliferative diffuse alveolar damage
[77]; in fact, these signs are observed in vivo at
Fig. 2 The lung ultrasound score (LUS) can be applied to assess the loss of aeration by dividing the thorax into 12 specific regions, six on the
right and six on the left in supine or prone position assign each region a score from 0 (normal lung) to 3 (lung consolidation). Anterior, lateral,
and posterior fields are identified by sternum, anterior, and posterior axillary lines. The entire examination can be performed without any change
in patient’s position. Score: 0 = normal aeration (A-lines and lung sliding or maximum 2 well-spaced B-lines); score 1 = moderate loss of aeration
(> = 3 well-spaced B-lines with lung sliding, coalescent B-lines/subpleural consolidations occupying < 50% of the pleural line); score 2 = severe
loss of aeration (> = 3 well-spaced B-lines with lung sliding, coalescent B-lines/subpleural consolidations occupying clearly > 50% of the pleural
line); score 3 = complete loss of aeration: lobar/hemilobar consolidation with predominant tissue like pattern
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admission in patients with long-duration symptoms [78].
When combined with suggestive clinical parameters and
compressive vein ultrasound, the presence of large sub-
pleural consolidations are associated with a high prob-
ability of pulmonary embolism [79].
E) Can LUS guide the titration of positive end
expiratory pressure in severe COVID-19 patients
receiving invasive mechanical ventilation?
Statement 10: LUS should be considered as an
additional tool for PEEP titration in COVID-19.
The limitations of LUS as a tool for titrating PEEP
levels in COVID-19 patients are the same as those ap-
plying to ARDS patients, namely, the limited capability
to quantify recruitment and detect hyperinflation. PEEP-
induced recruitment in COVID-19 is heterogeneous and
limited in most patients [80]. LUS should be considered
as an additional tool, complementary to respiratory me-
chanics and arterial blood gases, for determining and
monitoring the effects of PEEP changes [81].
F) Can LUS guide the use of prone positioning in
patients with severe COVID-19?
Statement 11: LUS should be integrated into the
assessment of patients considered potential responders
to prone positioning, according to the focal and non-
focal pattern of lung aeration loss.
Statement 12: LUS can be used to monitor variations in
lung aeration during prone positioning.
In conventional ARDS patients, lung ultrasound has
been used to monitor the effects of prone positioning on
lung reaeration [82, 83]. Haddam et al. showed that
ARDS patients with a focal distribution of aeration loss
as determined by LUS tended to experience greater
reaeration during prone positioning, although it did not
correlate with the oxygenation response [84]. In a sec-
ond study, aeration changes in posterior fields induced
by the first 3 h of prone positioning were significantly
greater in patients with positive responses and associated
with greater levels of oxygenation after 7 days of treat-
ment. Moreover, the lung aeration changes correlated
well with the reduction in dead space [85]. Rousset et al.
confirm that prone responders present a greater LUS
reaeration score at both an early and late stage of prone
positioning, corresponding with an increase in end-
expiratory lung volume [82]. Similarly, in COVID-19
pneumonia, the improvement in oxygenation following
pronation was associated with an improvement in both
the global and posterior LUS scores [85]. LUS was
proven to be a reliable bedside tool for monitoring lung
aeration across the different phases of prone positioning
in ARDS patients undergoing invasive mechanical venti-
lation. Thus, lung aeration monitoring through LUS im-
aging during pronation could also constitute a valid
solution for COVID-19 pneumonia, in which the early
prediction of disease progression may prove to be funda-
mental for the delivery of appropriate healthcare.
G) Can LUS help early diagnosis of pneumothorax in
severe COVID-19 patients undergoing invasive
mechanical ventilation?
Statement 13: LUS should be used in COVID-19 pa-
tients, in line with its clinical appropriateness as ascer-
tained by studies in non-COVID-19 patients.
Analysis of the current literature failed to reveal the
presence of studies specifically addressing LUS accuracy
in pneumothorax diagnosis in COVID-19 patients. A
single observational study by Li et al. [86], involving 42
patients, reported 4 cases of pneumothorax identified by
LUS and two cases identified by chest X-ray, but no data
on concordance were provided. A multi-center observa-
tional study by Zieleskiewicz et al. compared LUS per-
formance against that of CT as the standard reference in
the diagnosis of interstitial syndrome, consolidations,
pleural effusion, pneumothorax, and pleural irregularity
[5]. Unfortunately, no pneumothoraxes were present in
100 case samples; thus, the accuracy of LUS in pneumo-
thorax diagnosis could not be estimated. Consistently, a
low incidence of pneumothorax in COVID-19 patients
was previously reported by Yang et al. in a single-center
observational study of 52 patients [87]. Regarding
pneumothorax diagnosis and monitoring, LUS applica-
tions in COVID-19 patients must currently rely on non-
COVID-19 literature. To date, the role of LUS in
pneumothorax diagnosis in the critically ill and in
trauma patients is well-recognized [63]. Pneumothorax
is defined by the presence of air in the pleural cavity,
which, in the majority of cases, collects in the upper part
(i.e., in the least dependent part), depending on patient
position and habitus. Thus, where air collects, the vis-
ceral and parietal layers become separated, and a static
pleural line replaces normal lung appearance due to the
complete reflection of the US beam by the pleural air.
This static pleural line has three features: the absence of
lung sliding, the lack of B-lines, and the absence of lung
pulse [88–90]. Pneumothorax can be ruled out in 100%
of cases if lung sliding and B lines are present [7]. Only
one sign is specific enough to rule pneumothorax in the
lung-point [91]. This is the ultrasonographic sign that
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presents at the pneumothorax border where the visceral
and parietal pleural contact each other again. However,
lung-point can be challenging to find, or completely ab-
sent in very large pneumothorax cases. The accuracy of
LUS in pneumothorax diagnosis has been evaluated in
many studies, which have been synthesized into four
meta-analyses published between 2011 and 2014 [92–
95]. The pooled specificity of LUS is reported to vary be-
tween 98 and 99%, comparable to chest X-ray, while sensi-
tivity is reported to be between 79 and 91%, far
outperforming chest X-ray, the pooled sensitivity of which
varies from 40 to 52%. Moreover, LUS has been shown to
be a sensitive tool, with a low air volume threshold, able
to detect even radio-occult pneumothoraxes (i.e., un-
detected by chest X-ray), which may inflate further during
mechanical ventilation [96, 97]. LUS has also been shown
to be a reliable means for semi-quantifying pneumothorax
dimension, thus helping in treatment decision-making
[98]. In the context of pneumothorax daily reassessment,
some controversy exists regarding diagnostic consistency
over time, with only one study reporting LUS to be ad-
equately capable of detecting pneumothorax resolution
after chest drain clamping and removal [99]. The presence
of subcutaneous emphysema, which may accompany cases
of pneumomediastinum, may limit this application, com-
plicating mechanical ventilation in some COVID-19 pa-
tients [100].
H) Can LUS help the early diagnosis of ventilator-
associated pneumonia in severe COVID-19 patients
undergoing invasive mechanical ventilation?
Statement 14: LUS should be used in COVID-19 pa-
tients, in line with its clinical appropriateness as ascer-
tained by studies in non-COVID-19 patients.
Ventilator-associated pneumonia (VAP) is the most fre-
quent nosocomial infection occurring in the ICU; it is as-
sociated with increased mortality, a greater use of
antimicrobials, longer mechanical ventilation, and higher
healthcare costs. VAP is suspected in patients under
mechanical ventilation presenting fever/hypothermia,
leukocytosis/leukopenia, purulent tracheal secretions, and
impaired oxygenation [39]. No specific studies have been
conducted so far to assess the accuracy of LUS in VAP
diagnosis in COVID-19 patients. LUS is well suited to in-
vestigate interstitial and subpleural involvement in lung
disease, and it is increasingly used in the ICU setting. The
extent and severity of lung infiltrates can be described nu-
merically with a reproducible and validated LUS score
[39]. More recently, quantitative analysis of the LUS score
has been proposed to make the interpretation of findings
less operator dependent [6]. VAP-related injuries typically
extend from the center to the periphery of the lung; when
these lesions reach the subpleural regions, they become
identifiable by LUS: a normal A-line pattern with lung
sliding is replaced by focal areas of interstitial syndrome,
represented by well-spaced B-lines, becoming progres-
sively confluent into subpleural areas of consolidation,
where air-bronchograms may be visualized [68]. LUS
could become a tool for the detection of VAP in the ICU,
but this application has only been investigated so far by
three specific studies [6, 39, 68]. The current literature on
LUS use in routine practice for COVID-19 patients is en-
couraging as it seems to accurately reflect disease progres-
sion [39]. Specific data on LUS accuracy for the diagnosis
of VAP in severe COVID-19 patients undergoing invasive
mechanical ventilation are still lacking, and well-designed
studies are needed to validate this powerful tool [68].
I) Can LUS help the process of weaning severe
COVID-19 patients from invasive mechanical
ventilation?
Statement 15: We are unable to create any statement
on the use of LUS in the assessment of patient
readiness to sustain a spontaneous breathing trial
(SBT). No study has evaluated the potential of LUS for
this purpose in COVID-19 patients, and data in non-
COVID-19 patients are conflicting.
Statement 16: In association with standard clinical and
physiological indexes, LUS can improve the prediction
of SBT outcome in COVID-19 patients.
Statement 17: In association with standard clinical and
physiological indexes, LUS can improve the prediction
of extubation failure in COVID-19 patients.
The term weaning refers to the whole process leading
to the liberation from mechanical ventilation and re-
moval of the endotracheal tube [101]. The process in-
cludes a number of steps: (1) assessing spontaneous
breathing trial (SBT) readiness; (2) conducting a SBT
and assessing its outcome; and (3) predicting extubation
failure, which would expose patients to an increased risk
of death and prolonged ICU stay [101].
Readiness for SBT is commonly assessed by means of
a composite evaluation, including clinical and physio-
logical variables [101]. LUS imaging employed to ascer-
tain patient readiness to undergo an SBT has produced
conflicting results in non-COVID-19 patients. In critic-
ally ill neurosurgical patients, a high LUS score prior to
a 1-h SBT conducted using a T-tube was associated with
a higher risk of SBT failure [102]. Conversely, data from
a bi-center, prospective, observational investigation, car-
ried out in a heterogeneous population of 250 ready-to-
wean patients, showed that B-line predominance prior
Vetrugno et al. Journal of Anesthesia, Analgesia and Critical Care            (2021) 1:16 Page 9 of 16
to sustaining a T-tube SBT lasting 30–120 min was a
very weak predictor of SBT outcome, with 47% sensitiv-
ity, 64% specificity, a positive predictive value of 25%,
and a negative predictive value of 82% [103]. The au-
thors concluded that the presence of B-lines on a simpli-
fied 4-zone LUS protocol should not interfere with the
decision to initiate weaning procedures [103].
The outcomes of SBTs and extubation depend on a
variety of factors, such as cardiovascular dysfunction, in-
ability of the respiratory muscles to sustain an excessive
work of breathing, neuromuscular disorders, severe
anemia, altered metabolic, nutritional, or neuropsycho-
logical conditions, and the inability to clear secretions
[101]. While LUS is not helpful for evaluating some of
these factors, it may add to the physician’s decision-
making when associated with clinical and physiological
variables and in some cases with cardiac and diaphragm
ultrasound assessment [104–106]. In critically ill pa-
tients, following the reduction of ventilatory support, the
extension of regions affected by aeration loss and pul-
monary edema may contribute to weaning failure [105]
and can be identified and quantified by LUS [107, 108].
Indeed, variations in LUS patterns reflect changes in pul-
monary aeration, which is the final result of different
pathways [108–110]. Patients who fail an SBT show lung
de-recruitment and inhomogeneity according to electric
impedance tomography analysis [111]. In patients inva-
sively ventilated for more than 48 h, a 1-h SBT con-
ducted using a T-tube showed a LUS greater than that
observed in patients with successful SBT [104]. These
results were subsequently confirmed in a second study
conducted in the same setting [109]. In patients intu-
bated for acute respiratory failure of different etiologies
undergoing an SBT either in T-tube mode or with 8
cmH2O of inspiratory pressure support and 5 cmH2O of
positive end-expiratory pressure, the discriminative
power of LUS for successful weaning was 0.8 with a sen-
sitivity and specificity of 0.76 and 0.73, respectively
[112]. An increase in B-lines to ≥ 6 on four anterior
points during a 60-min SBT in T-tube mode was shown
to predict weaning-induced pulmonary edema with a
sensitivity of 88% (64–98) and a specificity of 88% (62–
98) [110]. In elderly patients undergoing an SBT, global
and anterolateral LUS predicted failure with a discrim-
inative power of 0.80 and 0.79, respectively [108].
Combining LUS with cardiac and diaphragmatic ultra-
sound assessment has the potential to improve weaning
failure prediction, providing insights into the origin of
reduced pulmonary aeration [113, 114]. A modified LUS
assessment and diaphragmatic thickening assessment
were associated with high predictive accuracy of success-
ful extubation, with an AUC of 0.78 and 0.76, respect-
ively, which increased up to 0.83 when considering both
assessments together [112]; however, the relationship
between LUS and diaphragm thickening during an SBT
seems to vary according to the degree of pulmonary
aeration [115], as well as to the considered subpopu-
lation [116]. LUS in association with the brain natri-
uretic peptide test, diaphragm dysfunction assessment,
and left atrial pressure measurement is a better pre-
dictor of weaning failure than LUS alone (AUC 0.91
vs 0.76) [117].
In non-COVID-19 patients, LUS was successfully
applied to predict extubation outcome. Regardless of
the primary cause of the weaning failure, LUS per-
formed in 100 ICU patients during successful SBTs in
T-tube mode was able to predict the occurrence of
post-extubation distress [112]. A LUS score higher
than 17 was associated with an increased risk of extu-
bation failure, whereas a gray zone was identified for
scores ranging from 13 to 17. In patients who suc-
cessfully passed the SBT with a LUS score > 13, non-
invasive ventilation was proposed as a rescue strategy
to prevent re-intubation [104]. LUS assessment during
successful SBTs with support pressure ventilation < 7
cmH2O and no PEEP revealed the occurrence of
multiple B-lines as a predictor of post-extubation dis-
tress within the first 48 h after extubation [113]. Des-
pite the lack of data in COVID-19 patients, the
pathophysiological insights gained from LUS during a
SBT to predict extubation failure might be translated
to COVID-19 patients. This suggestion arrives from
the consideration that observational studies have eval-
uated the reliability of LUS as a monitoring tool in
COVID-19 patients, despite it being a different clin-
ical setting to weaning [42].
Changes in the LUS score during SBTs in COVID-19
patients could add some information concerning the loss
of aeration. Cardiac and diaphragm ultrasound assess-
ments might also be able to enhance SBT outcome
prediction.
L) Can LUS decrease the need for radiologic chest im-
aging in severe COVID-19 patients?
Statement 18: In patients with known COVID-19 and
severe symptoms, LUS should be performed instead of
radiologic chest imaging as the first-line imaging test to
monitor disease progression.
Statement 19: LUS findings suggestive of pneumonia
can render additional imaging techniques unnecessary,
especially when the likelihood of an alternative
diagnosis is low.
Statement 20: In COVID-19 patients with severe symp-
toms, a negative LUS exam should prompt an add-
itional radiologic chest imaging work-up.
Monitoring critically ill patients by serial chest X-ray
is not advisable due to the technique’s low sensitivity
Vetrugno et al. Journal of Anesthesia, Analgesia and Critical Care            (2021) 1:16 Page 10 of 16
and long execution time; moreover, it represents a sub-
optimal allocation of available resources [19].
Conversely, LUS demonstrates high agreement with
chest computer tomography (CT), closely mirrors the lon-
gitudinal changes found by CT without exposing the
personnel to infection risks, and is quick to perform [9]. If
integrated into the daily routine examinations, LUS results
appear to accurately reflect disease progression, thus redu-
cing the need for chest X-ray and CT [41–118]. Moreover,
LUS has been shown capable of monitoring the evolution
of severe COVID-19 pneumonia after hospital discharge,
supporting its integration into clinical predictive models
of residual lung injury, thus providing an alternative im-
aging modality for the diagnosis and monitoring of critic-
ally ill COVID-19 patients [119].
If a patient presents LUS findings suggestive of pneu-
monia together with a low pre-test probability of an al-
ternative or secondary diagnosis, an additional imaging
modality may not be necessary [1–120]; however, a chest
CT on admission performs better than LUS for COVID-
19 diagnosis, at varying disease prevalence [38], and LUS
is highly sensitive but not specific for COVID-19 [121].
Thus, the presence of pre-existing conditions, such as
chronic obstructive pulmonary disease or heart failure,
and the prevalence of venous thromboembolism in pa-
tients with COVID-19 must be taken into account when
deciding whether to pursue or not additional chest im-
aging modalities, which should be individualized on a
patient-by-patient basis [120].
In patients with severe symptoms, the probability of
entirely normal radiologic findings is low. Thus, in pa-
tients with severe symptoms, a negative LUS should
prompt additional radiologic chest imaging work-up by
chest CT owing to its higher accuracy in imaging cen-
trally based abnormalities and diagnosis of pulmonary
embolism [122–124].
Discussion
The panel produced 20 statements in relation to 10
clinical questions on the bedside use of LUS in
COVID-19 critically ill patients, summarizing the lat-
est available literature and the direct experience of
the expert panelists. As the use of LUS became in-
eluctable during this pandemic, anesthesiologists and
intensive care physicians have been quick to incorpor-
ate this important tool into their armamentarium [1,
2, 4–6, 9]. This also reinforces the need to impose
training and certification on the use of this tool
within our discipline in order to ensure its wider im-
plementation in the near future [125]. Two other
groups have proposed consensuses on the use of LUS
in the setting of COVID-19 [12, 126]. The Canadian
consensus statement on the use of LUS was focused
on the assessment of medical inpatients to confirm or
rule out the diagnosis of COVID-19 pneumonia [12].
Our consensus not only confirms the use of LUS for
COVID-19 pneumonia diagnosis but also details its
use as a monitoring tool in the critically ill. A second
multi-organ point-of-care ultrasound consensus for
COVID-19 patients included a whole-body ultrasound
approach [126]. While it supports the use of LUS as
an accurate diagnostic tool, the specific use of LUS in
routine ICU work was not detailed. Two other society
guidelines have been produced: the first by the Ger-
man societies of clinical acute, emergency, and inten-
sive care medicine and radiology [127] and the
second by the British Medical Ultrasound Society
(BMUS) [128]. Both are mainly focused on imaging
and monitoring techniques in COVID-19, but do not
detail the use of LUS in the critically ill. Finally, the
European Society of Radiology recently highlighted
the role of lung ultrasound in COVID-19 disease in
the ICU, supporting its use “to track the evolution of
disease during follow-up and to monitor lung recruit-
ment maneuvers, the response to prone position ven-
tilation and the controlling of extracorporeal
membrane therapy” [2].
Conclusions
In conclusion, our expert consensus is the first detailing
the use of LUS for diagnosis, management, and monitor-
ing of COVID-19 pneumonia in the critically ill patient.
We hope that the statements produced will help ICU
physicians in their daily clinical practice while facing the
ongoing pandemic.
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